US Patent

US11753301 — Sodium thiosulfate-containing pharmaceutical compositions

Method of Use · Assigned to Hope Medical Enterprises Inc · Expires 2030-02-10 · 4y remaining

Vulnerability score 76/100 Vulnerable — likely target for IPR or design-around

What this patent protects

This patent protects methods of treatment using pharmaceutically acceptable sodium thiosulfate.

USPTO Abstract

Provided herein are pharmaceutically acceptable sodium thiosulfate and pharmaceutical compositions thereof. Also provided herein are methods for determining the total non-purgeable organic carbon in a sodium thiosulfate-containing sample. Further provided herein are methods for producing pharmaceutically acceptable sodium thiosulfate. Still further provided herein are methods of treatment comprising the administration of pharmaceutically acceptable sodium thiosulfate.

Drugs covered by this patent

FDA Patent Use Codes

When a patent is method-of-use, FDA lists it once per applicable indication ("U-code"). Each U-code carves out a specific therapeutic use that generic filers must either license or design around.

CodeDescriptionDrug
U-3681 — Sodium Nitrite
U-3682 — Sodium Thiosulfate

Patent Metadata

Patent number
US11753301
Jurisdiction
US
Classification
Method of Use
Expires
2030-02-10
Drug substance claim
Yes
Drug product claim
Yes
Assignee
Hope Medical Enterprises Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.